116 related articles for article (PubMed ID: 7629726)
1. Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification.
Ludeman SM; Shulman-Roskes EM; Wong KK; Han SY; Anderson LW; Strong JM; Colvin OM
J Pharm Sci; 1995 Apr; 84(4):393-8. PubMed ID: 7629726
[TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood.
Anderson LW; Ludeman SM; Colvin OM; Grochow LB; Strong JM
J Chromatogr B Biomed Appl; 1995 May; 667(2):247-57. PubMed ID: 7663697
[TBL] [Abstract][Full Text] [Related]
4. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide.
Zon G; Ludeman SM; Sweet EM; Egan W; Phillips LR
J Pharm Sci; 1982 Apr; 71(4):443-6. PubMed ID: 7086655
[TBL] [Abstract][Full Text] [Related]
5. Direct detection of the intracellular formation of carboxyphosphamides using nuclear magnetic resonance spectroscopy.
Boal JH; Ludeman SM; Ho CK; Engel J; Niemeyer U
Arzneimittelforschung; 1994 Jan; 44(1):84-93. PubMed ID: 8135883
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of the O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine oximes of selected carbonyl compounds and their determination by liquid chromatography with ultraviolet detection.
Wiesenthal K; Jehlar A; Que Hee SS; Wiesenthal K; Jehlar A; Que Hee SS
J AOAC Int; 2000; 83(4):859-69. PubMed ID: 10995112
[TBL] [Abstract][Full Text] [Related]
8. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
[TBL] [Abstract][Full Text] [Related]
9. Tandem mass spectrometric analysis of cyclophosphamide, ifosfamide and their metabolites.
Liu Z; Chan KK; Wang JJ
Rapid Commun Mass Spectrom; 2005; 19(18):2581-90. PubMed ID: 16106352
[TBL] [Abstract][Full Text] [Related]
10. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
Borch RF; Hoye TR; Swanson TA
J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051
[TBL] [Abstract][Full Text] [Related]
11. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
12. [Fluorometric determination of "activated" cyclophosphamide and ifosfamide in blood (author's transl)].
Voelcker G; Haeglsperger R; Hohorst HJ
J Cancer Res Clin Oncol; 1979 Apr; 93(3):233-40. PubMed ID: 468886
[TBL] [Abstract][Full Text] [Related]
13. 31P nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites.
Boyd VL; Robbins JD; Egan W; Ludeman SM
J Med Chem; 1986 Jul; 29(7):1206-10. PubMed ID: 3543359
[TBL] [Abstract][Full Text] [Related]
14. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
Chen TL; Kennedy MJ; Anderson LW; Kiraly SB; Black KC; Colvin OM; Grochow LB
Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
[TBL] [Abstract][Full Text] [Related]
15. Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide.
Štenglová Netíková IR; Petruželka L; Šťastný M; Štengl V
Int J Nanomedicine; 2018; 13():7971-7985. PubMed ID: 30538471
[TBL] [Abstract][Full Text] [Related]
16. Quantification of 4-hydroxyifosfamide in plasma of ifosfamide-treated mice.
Struck RF; McCain DM; Tendian SW; Tillery KH
Cancer Chemother Pharmacol; 1997; 40(1):57-9. PubMed ID: 9137530
[TBL] [Abstract][Full Text] [Related]
17. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. 2. Direct observation, characterization, and reactivity studies of iminocyclophosphamide and related species.
Boyd VL; Summers MF; Ludeman SM; Egan W; Zon G; Regan JB
J Med Chem; 1987 Feb; 30(2):366-74. PubMed ID: 3806617
[TBL] [Abstract][Full Text] [Related]
18. Analysis of aldehydes via headspace SPME with on-fiber derivatization to their O-(2,3,4,5,6-pentafluorobenzyl)oxime derivatives and comprehensive 2D-GC-MS.
Schmarr HG; Sang W; Ganss S; Fischer U; Köpp B; Schulz C; Potouridis T
J Sep Sci; 2008 Oct; 31(19):3458-65. PubMed ID: 18798218
[TBL] [Abstract][Full Text] [Related]
19. Effect of stereochemistry on the oxidative metabolism of the cyclophosphamide metabolite aldophosphamide.
Habib AD; Boal JH; Hilton J; Nguyen T; Chang YH; Ludeman SM
Biochem Pharmacol; 1995 Jul; 50(3):429-33. PubMed ID: 7646546
[TBL] [Abstract][Full Text] [Related]
20. Initial measurements of ifosfamide and cyclophosphamide in patients using (31)P MRS: pulse-and-acquire, decoupling, and polarization transfer.
Payne GS; Pinkerton CR; Bouffet E; Leach MO
Magn Reson Med; 2000 Aug; 44(2):180-4. PubMed ID: 10918315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
